Rockwell Collins Inc. (COL) Pops 3.38% for February 15

Equities Staff |

One of the S&P 500’s big winners for Monday February 15 was Rockwell Collins Inc. (COL) as the company’s stock climbed 3.38% to $80.95 on volume of 1.42 million shares.

The stock opened at $78.90 and saw an intraday low of $78.55 and an intraday high of $80.99. All told, the day saw a per-share gain of $2.65. The stock’s average daily volume of 850,247 and 131.13 million shares outstanding. Rockwell Collins Inc. now has a 50-day SMA is $86.55 and 200-day SMA is $87.83, and it has a 52-week high of $99.37 and a 52-week low of $76.03.

Rockwell Collins Inc designs, produces & supports communications & aviation systems for commercial & military customers & provides information management services through voice and data communication networks and solutions.

Based out of Cedar Rapids, IA, Rockwell Collins Inc. has 19,500 employees and, after today’s trading, reached a market cap of $10.62 billion. The stock’s P/E Ratio is 16. Its P/S ratio is 2.5, P/B ratio is 5.59, and P/FCF ratio is 36.9.

For a complete fundamental analysis analysis of Rockwell Collins Inc., check out’s Stock Valuation Analysis report for COL. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…